UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 26, 2024 4:30 P.M.
Form:
F-3
CIK:
0001783036
Company Name:
NLS Pharmaceutics Ltd.
File Number:
333-282788